BioNexus Gene Lab Corp. Foreign Currency Transaction Gain, before Tax
BioNexus Gene Lab Corp. (BGLC) reported Foreign Currency Transaction Gain, before Tax of $46 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ForeignCurrencyTransactionGainBeforeTax · last filed 2026-08-14
- BioNexus Gene Lab Corp. foreign currency transaction gain, before tax for the quarter ending 2026-06-30 was $46.00.
- BioNexus Gene Lab Corp. foreign currency transaction gain, before tax for the quarter ending 2025-06-30 was $0.00.
- BioNexus Gene Lab Corp. foreign currency transaction gain, before tax for the quarter ending 2020-03-31 was -$41.68K.
- BioNexus Gene Lab Corp. foreign currency transaction gain, before tax for the quarter ending 2019-09-30 was -$10.80K.
| Period end | Foreign Currency Transaction Gain, before Tax 3 month | Foreign Currency Transaction Gain, before Tax 6 month | Foreign Currency Transaction Gain, before Tax 9 month | Foreign Currency Transaction Gain, before Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $46.00 10-Q · filed 2026-08-14 | $5.66K 10-Q · filed 2026-08-14 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | ||
| 2020-03-31 | -$41.68K 10-Q · filed 2020-05-08 | |||
| 2019-12-31 | $9.87K 10-Q · filed 2020-05-08 | |||
| 2019-09-30 | -$10.80K 10-Q · filed 2019-11-14 | -$28.40K derived: sum of 2 quarters · filed 2019-11-14 | -$39.66K derived: sum of 3 quarters · filed 2019-11-14 | |
| 2019-06-30 | -$17.60K 10-Q · filed 2019-11-14 | -$28.86K derived: sum of 2 quarters · filed 2019-11-14 | ||
| 2019-03-31 | -$11.26K 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |